Trial Outcomes & Findings for Pain Medicine for Wound Care Procedures (NCT NCT00701909)

NCT ID: NCT00701909

Last Updated: 2024-03-26

Results Overview

The degree of pain described by participants on a numeric rating scale of 0 to 10, where 0 = no pain and 10 = worst pain imaginable

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

12 participants

Primary outcome timeframe

Immediately after the wound care procedure

Results posted on

2024-03-26

Participant Flow

Participant milestones

Participant milestones
Measure
Morphine Plus Ketamine, Then Morphine Plus Saline
During the first wound care procedure, patients received morphine 0.05 mg/kg (a maximum dose of 4 mg) plus ketamine 0.25 mg/kg. Then, during the second wound care procedure, they were cross-over to receive morphine 0.1 mg/kg plus Saline.
Morphine Plus Saline, Then Morphine Plus Ketamine
During the first wound care procedure, patients received morphine 0.1 mg/kg (a maximum dose of 8 mg) plus saline. Then, they were cross-over to receive morphine 0.05 mg/kg (a maximum dose of 4 mg) plus ketamine 0.25 mg/kg.
Overall Study
STARTED
7
5
Overall Study
COMPLETED
7
4
Overall Study
NOT COMPLETED
0
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Morphine Plus Ketamine, Then Morphine Plus Saline
During the first wound care procedure, patients received morphine 0.05 mg/kg (a maximum dose of 4 mg) plus ketamine 0.25 mg/kg. Then, during the second wound care procedure, they were cross-over to receive morphine 0.1 mg/kg plus Saline.
Morphine Plus Saline, Then Morphine Plus Ketamine
During the first wound care procedure, patients received morphine 0.1 mg/kg (a maximum dose of 8 mg) plus saline. Then, they were cross-over to receive morphine 0.05 mg/kg (a maximum dose of 4 mg) plus ketamine 0.25 mg/kg.
Overall Study
Withdrawal by Subject
0
1

Baseline Characteristics

Pain Medicine for Wound Care Procedures

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Morphine Plus Ketamine First
n=7 Participants
During the first wound care procedure, patients received morphine 0.05 mg/kg (maximum dose of 4 mg) plus ketamine 0.25 mg/kg. Then, during the second wound care procedure, they received morphine 0.1 mg/kg (maximum dose of 8 mg) plus saline.
Morphine Plus Saline First
n=4 Participants
During the first wound care procedure, patients received morphine 0.1 mg/kg (maximum dose of 8 mg) plus saline. Then, during the second wound care procedure, they received morphine 0.05 mg/kg (maximum dose of 4 mg) plus ketamine 0.25 mg/kg.
Total
n=11 Participants
Total of all reporting groups
Age, Continuous
32.1 years
STANDARD_DEVIATION 9.6 • n=5 Participants
32.5 years
STANDARD_DEVIATION 4.4 • n=7 Participants
32.3 years
STANDARD_DEVIATION 7.8 • n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
4 Participants
n=7 Participants
11 Participants
n=5 Participants
Region of Enrollment
Puerto Rico
7 participants
n=5 Participants
4 participants
n=7 Participants
11 participants
n=5 Participants

PRIMARY outcome

Timeframe: Immediately after the wound care procedure

The degree of pain described by participants on a numeric rating scale of 0 to 10, where 0 = no pain and 10 = worst pain imaginable

Outcome measures

Outcome measures
Measure
Morphine Plus Ketamine
n=11 Participants
Participants who received morphine 0.05 mg/kg (a maximum dose of 4 mg) plus ketamine 0.25 mg/kg IV in either the first or second wound care procedure.
Morphine Plus Saline
n=11 Participants
Participants who received morphine 0.1 mg/kg (a maximum dose of 8 mg) plus saline IV in either the first or second wound care procedure.
Pain Intensity
3.1 score on a scale
Standard Error .99
6.8 score on a scale
Standard Error .92

SECONDARY outcome

Timeframe: Immediately after the procedure

Short-form McGill Pain Questionnaire. The questionnaire has 15 adjectives to describe the pain. Each is rated on a 4-point scale (i.e., none, mild, moderate, or severe. Total wound pain quality score can range from 0 to 45.

Outcome measures

Outcome measures
Measure
Morphine Plus Ketamine
n=11 Participants
Participants who received morphine 0.05 mg/kg (a maximum dose of 4 mg) plus ketamine 0.25 mg/kg IV in either the first or second wound care procedure.
Morphine Plus Saline
n=11 Participants
Participants who received morphine 0.1 mg/kg (a maximum dose of 8 mg) plus saline IV in either the first or second wound care procedure.
Wound Pain Quality
13.6 units on a scale
Standard Error 3.6
17.6 units on a scale
Standard Error 3.7

Adverse Events

Morphine Plus Ketamine

Serious events: 0 serious events
Other events: 10 other events
Deaths: 0 deaths

Morphine Plus Saline

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Morphine Plus Ketamine
n=11 participants at risk
Patients received morphine 0.05 mg/kg (maximum dose of 4 mg) plus ketamine 0.25 mg/kg (MK) during the first or second wound care procedure according to randomization
Morphine Plus Saline
n=11 participants at risk
Patients received morphine 0.1 mg/kg (maximum dose of 8 mg) plus saline (MS) during the first or second wound care procedure according to randomization
Nervous system disorders
strange sensations
90.9%
10/11 • Number of events 10
0.00%
0/11

Additional Information

Dr. Kathleen Puntillo, RN, PhD

University of California, San Francisco

Phone: 415 819 2655

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place